True, the longer-term top line has been declining since January 2022 ... but the smaller line that started in January 2023 gives reason for hope. If the merger is successful, the share price could break through the longer-term line from bottom to top in the not too distant future ...At least there is fantasy in the current situation!
- Forums
- ASX - By Stock
- TA
ACL
australian clinical labs limited
Add to My Watchlist
0.00%
!
$2.83

True, the longer-term top line has been declining since January...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$2.83 |
Change
0.000(0.00%) |
Mkt cap ! $555.7M |
Open | High | Low | Value | Volume |
$2.85 | $2.86 | $2.81 | $4.431M | 1.570M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 25431 | $2.81 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.86 | 11164 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 25431 | 2.810 |
8 | 9617 | 2.800 |
1 | 3580 | 2.790 |
3 | 16261 | 2.780 |
2 | 3517 | 2.770 |
Price($) | Vol. | No. |
---|---|---|
2.860 | 11164 | 3 |
2.890 | 3000 | 1 |
2.900 | 7924 | 3 |
2.910 | 50000 | 1 |
2.920 | 67 | 1 |
Last trade - 16.10pm 28/07/2025 (20 minute delay) ? |
Featured News
ACL (ASX) Chart |